Global Genome Editing Market Overview:
Global Genome Editing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Genome Editing Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Genome Editing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Genome Editing Market:
The Genome Editing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Genome Editing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Genome Editing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Genome Editing market has been segmented into:
Messenger RNA Modification
Transfer RNA Modification
Ribosomal RNA Modification
By Application, Genome Editing market has been segmented into:
Cancer
Genetic Disorders And Temporary Maladies
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Genome Editing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Genome Editing market.
Top Key Players Covered in Genome Editing market are:
ProQR Therapeutics NV
Sirna Therapeutics
Inc.
Shape Therapeutics
Inc.
Korro Bio
Inc.
Beam Therapeutics
Inc.
QIAGEN N.V.
UniQure NV (UniQure)
LAVA Therapeutics N.V.
argenx SE
Arrowhead Pharmaceuticals
Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Genome Editing Market Type
4.1 Genome Editing Market Snapshot and Growth Engine
4.2 Genome Editing Market Overview
4.3 Messenger RNA Modification
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Messenger RNA Modification: Geographic Segmentation Analysis
4.4 Transfer RNA Modification
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Transfer RNA Modification: Geographic Segmentation Analysis
4.5 Ribosomal RNA Modification
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Ribosomal RNA Modification: Geographic Segmentation Analysis
Chapter 5: Genome Editing Market Application
5.1 Genome Editing Market Snapshot and Growth Engine
5.2 Genome Editing Market Overview
5.3 Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Cancer: Geographic Segmentation Analysis
5.4 Genetic Disorders And Temporary Maladies
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Genetic Disorders And Temporary Maladies: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Genome Editing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 PROQR THERAPEUTICS NV
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 SIRNA THERAPEUTICS
6.4 INC.
6.5 SHAPE THERAPEUTICS
6.6 INC.
6.7 KORRO BIO
6.8 INC.
6.9 BEAM THERAPEUTICS
6.10 INC.
6.11 QIAGEN N.V.
6.12 UNIQURE NV (UNIQURE)
6.13 LAVA THERAPEUTICS N.V.
6.14 ARGENX SE
6.15 ARROWHEAD PHARMACEUTICALS
6.16 INC.
Chapter 7: Global Genome Editing Market By Region
7.1 Overview
7.2. North America Genome Editing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Messenger RNA Modification
7.2.2.2 Transfer RNA Modification
7.2.2.3 Ribosomal RNA Modification
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Cancer
7.2.3.2 Genetic Disorders And Temporary Maladies
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Genome Editing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Messenger RNA Modification
7.3.2.2 Transfer RNA Modification
7.3.2.3 Ribosomal RNA Modification
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Cancer
7.3.3.2 Genetic Disorders And Temporary Maladies
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Genome Editing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Messenger RNA Modification
7.4.2.2 Transfer RNA Modification
7.4.2.3 Ribosomal RNA Modification
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Cancer
7.4.3.2 Genetic Disorders And Temporary Maladies
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Genome Editing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Messenger RNA Modification
7.5.2.2 Transfer RNA Modification
7.5.2.3 Ribosomal RNA Modification
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Cancer
7.5.3.2 Genetic Disorders And Temporary Maladies
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Genome Editing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Messenger RNA Modification
7.6.2.2 Transfer RNA Modification
7.6.2.3 Ribosomal RNA Modification
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Cancer
7.6.3.2 Genetic Disorders And Temporary Maladies
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Genome Editing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Messenger RNA Modification
7.7.2.2 Transfer RNA Modification
7.7.2.3 Ribosomal RNA Modification
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Cancer
7.7.3.2 Genetic Disorders And Temporary Maladies
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Genome Editing Scope:
|
Report Data
|
Genome Editing Market
|
|
Genome Editing Market Size in 2025
|
USD XX million
|
|
Genome Editing CAGR 2025 - 2032
|
XX%
|
|
Genome Editing Base Year
|
2024
|
|
Genome Editing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
ProQR Therapeutics NV, Sirna Therapeutics, Inc., Shape Therapeutics, Inc., Korro Bio, Inc., Beam Therapeutics, Inc., QIAGEN N.V., UniQure NV (UniQure), LAVA Therapeutics N.V., argenx SE, Arrowhead Pharmaceuticals, Inc..
|
|
Key Segments
|
By Type
Messenger RNA Modification
Transfer RNA Modification
Ribosomal RNA Modification
By Applications
Cancer
Genetic Disorders And Temporary Maladies
|
